Stem cells, exosomes, gene therapy, peptides, hyperbaric oxygen, and epigenetic reprogramming
390 articles
Découvrez comment des médicaments révolutionnaires ciblent les « cellules zombies » qui s'accumulent avec l'âge, ouvrant potentiellement la voie à un renversement du vieillissement et à une extension de la durée de vie en bonne santé.
Revolution Medicines' RAS inhibitor daraxonrasib shows breakthrough results in pancreatic cancer, doubling patient survival times.
BioNTech reports positive Phase 2 results for HER2-targeted cancer therapy, with FDA filing planned to compete with existing treatments.
New 'off-the-shelf' CAR-T therapy eliminated detectable lymphoma cells in over half of treated patients in early clinical data.
New approach to treating childhood wrist fractures may improve outcomes by prioritizing immediate casting over other interventions.
Researchers developed a new method to create aligned fibers from tendon tissue that maintain natural proteins and support cell growth.
New review reveals strategies to make laser bone cutting faster and safer than traditional mechanical tools for surgery.
Scientists develop photoswitchable peptides that can be activated with light for precise drug delivery and targeted therapy.
Five beta thalassemia patients no longer need regular blood transfusions after Chinese gene therapy treatment.
FDA denies approval for innovative virus-based melanoma treatment due to unresolved clinical trial concerns from Massachusetts biotech company.
Temperature-controlled plasma offers precise, minimally invasive treatment for laryngocele removal with improved surgical outcomes.
Novel iodide-enhanced hydrogel penetrates gum pockets to eliminate harmful bacteria while protecting regenerative stem cells.
